I. Ramírez

发表

Contraception in cancer survivors – an expert review Part I. Breast and gynaecological cancers

A. Gompel, J. Bitzer, I. Ramírez, 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Eligibility criteria for menopausal hormone therapy (MHT): A consortium of scientific societies for the use of MHT in women with medical conditions. Research protocol.

A. Cano, I. Solá, J. Vázquez, 2021, Maturitas.

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

A. Cano, J. Paramo, M. J. Cancelo, 2020, Maturitas.

Contraception in cancer survivors – an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers

A. Gompel, A. Cagnacci, J. Bitzer, 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.

Z. Benítez, T. Simoncini, J. Calaf, 2022, Maturitas.

The Vasodilatory Effects of Levosimendan on the Human Internal Mammary Artery

F. Montes, J. Umaña, Lorena Buitrago, 2006, Anesthesia and analgesia.

Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study

P. Tajada, M. Lamarca, L. Baquedano, 2020, BMC Women's Health.

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

H. Jessen, M. Pangalos, R. Fischer, 2022, The Lancet Respiratory Medicine.

Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study

P. Tajada, M. Lamarca, L. Baquedano, 2021, BMC Women's Health.

Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis

F. Martínez, E. Pérez-Campos, I. Lete, 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.

F. Martínez, E. Pérez-Campos, I. Lete, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Population-based survey on menopausal symptoms and treatment use

L. Baquedano, P. Llaneza, P. Coronado, 2022, Climacteric : the journal of the International Menopause Society.

The thromboembolic risk in covid-19 women under hormonal treatment group

A. Cano, J. Paramo, M. J. Cancelo, 2020, Maturitas.

Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review

J. Calaf, L. Baquedano, A. Santaballa, 2023, Journal of clinical medicine.